Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer
Gunter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, Jana Barinoff, Christoph Mundhenke, Tanja Cufer, Eduard Maartense, Felix E. de Jongh, Klaus H. Baumann, Joachim Bischoff, Nadia Harbeck, Hans-JVolume:
47
Year:
2011
Language:
english
Pages:
2282
DOI:
10.1016/j.ejca.2011.06.021
File:
PDF, 616 KB
english, 2011